Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.

This study has been terminated.
(This study was terminated for administrative reasons)
Department of Health and Human Services
Information provided by (Responsible Party):
BioCryst Pharmaceuticals Identifier:
First received: October 19, 2010
Last updated: December 15, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 14, 2011